---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-022897"
form_type: "8-K/A"
ticker: "SRRK"
cik: "0001727196"
company_name: "Scholar Rock Holding Corp"
filed_at: "2026-03-03T23:59:59+00:00"
generated_at: "2026-05-15T22:18:09.424877+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Scholar Rock widens FY2025 net loss to $377.9M; corrects Q4 EPS to $0.76; BLA resubmission path cleared

## Summary
- Q4 2025 net loss of $91.0M ($0.76 per share, corrected); FY2025 net loss $377.9M ($3.29 per share), up from $246.3M in 2024.
- No revenue; cash, equivalents, and marketable securities of $367.6M as of Dec 31, 2025.
- Apitegromab BLA resubmission expected in 2026 after FDA constructive meeting with Catalent Indiana; no additional corrective actions.
- New debt facility up to $550M from Blue Owl Capital provides non-dilutive capital; $100M drawn at closing, $100M available Q1 2026, $150M upon FDA approval.
- EMA decision on MAA expected mid-2026; European launch planned H2 2026 starting with Germany.

## SEC filing metadata
- accession: 0001104659-26-022897
- form_type: 8-K/A
- ticker: SRRK
- cik: 0001727196
- company_name: Scholar Rock Holding Corp
- filed_at: 2026-03-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1727196/000110465926022897/0001104659-26-022897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1727196/000110465926022897/tm267900d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-022897
- JSON: https://secwatch.observer/filing/0001104659-26-022897.json
- Plain text: https://secwatch.observer/filing/0001104659-26-022897.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.